ACON Stock Performance and Moving Averages. In recent trading, Aclarion Inc (ACON) stock price has shown some volatility, fluctuating 1.65% over the last five trades and -62.30% o ...

Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help ...

(Nasdaq: ACON), a company specializing in cutting-edge healthcare technology, saw its stock price surge by +6.44%, reaching $0.0479 during Friday’s premarket trading session. The jump follows the ...

Aclarion, Inc. (ACON) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

EQS-News: Aclarion, Inc. / Key word (s): Financial Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants 15.01.2025 / 15:21 CET/CEST The issuer is solely ...

Aclarion Inc (NASDAQ:ACON) stock rocketed higher on Friday on heavy trading volume. However, there is no news to justify the stock movement. Last week, Aclarion announced the product release of ...

Comparatively, Aclarion has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Aclarion has a consensus price target of $1.30, indicating a potential upside of ...

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes ...

BROOMFIELD, CO - January 17, 2025 (NEWMEDIAWIRE) - Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary ...

Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...